Expansion plans in Texas put Encompass Health in focus
Encompass Health (EHC) has drawn fresh attention after unveiling plans to grow inpatient rehabilitation capacity in Montgomery County, Texas, through a new small-format hospital in Conroe and a replacement facility in The Woodlands.
The expansion news comes after a strong rise in the Encompass Health share price. The company has a 90-day share price return of 13.1% and a year-to-date share price return of 17.2%. Longer term, total shareholder returns of 93.4% over three years and 142.6% over five years indicate that momentum has been building rather than fading.
Surf 34 healthcare AI stocks to see which other healthcare specialists, alongside Encompass Health, are trying to turn rising patient demand into long-term share price momentum.The recent rise puts Encompass Health in a different light. Is this move mainly a reaction to the Texas expansion headlines, or a clearer read on what the established rehabilitation model is worth?
Most Popular Narrative: 16% Undervalued
On the widely followed narrative, Encompass Health is priced below an assessed fair value of $148.17, compared with a last close of $124.69. For anyone watching the Texas build out, that gap frames how much weight the market gives to the longer term expansion story.
Ongoing expansion of Encompass Health’s inpatient rehabilitation footprint through de novo hospitals, bed additions at high occupancy sites, and small format facilities, supported by a disclosed multi year pipeline and high returns on these projects, points to further discharge volume growth that can lift net operating revenue and EBITDA.
See why 6 investors see Encompass Health as 16% undervalued.
Result: Fair Value of $148.17 (UNDERVALUED)
Still, the Encompass Health story can be knocked off course if tougher Medicare Advantage approval trends persist or if new hospitals and bed additions underperform their targeted economics.
Find out about the key risks to this Encompass Health narrative.
Next Steps
Mixed signals on Encompass Health so far. Act while the information is fresh, weigh the upside against the pressure points, and review the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Encompass Health?
If Encompass Health has your attention, do not stop here. Broaden your watchlist with fresh opportunities that match your style and risk comfort.
- Target deep value potential by scanning companies that screen as underpriced on both quality and fundamentals through the 27 high quality undervalued stocks.
- Build a steadier income base by focusing on companies that pay robust yields and aim for resilience using the 8 dividend fortresses.
- Dial up defense in your portfolio by zeroing in on financially sound operators via the list of solid balance sheet and fundamentals (25 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com